Several layers of difficulty are likely to impinge on any therapy targeting ISG15, given its multiple substrates and cellular functions (including pathogen defense and tumor suppression), its context-specific effects, and the complexity of the pro-inflammatory pathways in which it participates. This evidence concerns the gene ISG15 and neoplasm.